Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange
June 18, 2022 at 14:19 PM EDT
Joincare Pharmaceutical of Shenzhen plans to list on the SIX Swiss stock exchange, an unusual venue for a China biopharma. The company said it aims to broaden its financing sources and increase global expansion.
